Amgen Inc. Dividend History (AMGN)
Amgen Inc. will distribute a dividend of $2.25 per share on December 9, 2024 (5 days)
🤑 Amgen Inc. has distributed a total of 53 dividends from 2011 to 2024
📈 During this 13 period their dividend has seen a 703.57% increase in the payout amount
About Amgen Inc.
Amgen Inc. is a leading biotechnology company, renowned for its innovative approach to developing therapies that advance health outcomes for patients around the globe. Founded in 1980 and headquartered in Thousand Oaks, California, Amgen focuses on discovering, developing, manufacturing, and delivering human therapeutics. Their portfolio includes treatments for serious illnesses such as cardiovascular disease, cancer, and inflammation. Under the leadership of CEO Robert A. Bradway, Amgen has continued to expand its reach and impact within the healthcare sector. As of 2022, the company reported substantial revenue, reflecting its robust pipeline and successful commercialization strategies. Known for its pioneering spirit, Amgen remains committed to unlocking the potential of biology for patients suffering from severe diseases.
AbbVie Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Gilead Sciences, Inc.
Johnson & Johnson
Merck & Co., Inc.
Moderna, Inc.
Pfizer Inc.
Vertex Pharmaceuticals Incorporated
Eli Lilly's weight loss drug Zepbound remains dominant in the market, with a potential competitor Amgen's MariTide failing to meet expectations in clinical trials. The article also discusses Eli Lilly's strong pipeline and the potential for Medicare and Medicaid coverage of weight loss drugs, which could further boost Eli Lilly's sales.
The Motley Fool · Published on Wed Dec 04 2024
Amgen's weight loss drug candidate MariTide faces competition from Eli Lilly's Zepbound and Novo Nordisk's Wegovy. While MariTide has a convenience advantage with monthly dosing, its efficacy and tolerability are not significantly better than the incumbents. Amgen's stock is still worth buying on the dip as MariTide could potentially fill a niche for more tolerable and convenient weight loss solutions.
The Motley Fool · Published on Sat Nov 30 2024
Novo Nordisk, a Danish pharmaceutical company, has seen strong growth in recent years due to its GLP-1 drugs. While the company faces increasing competition, its pipeline of obesity and diabetes treatments, including the promising semaglutide, suggests continued growth potential. However, the stock's valuation and the competitive landscape warrant caution.
The Motley Fool · Published on Fri Nov 29 2024Previous Payouts (53)
The most recent dividend Amgen Inc. paid out was on September 6, 2024 (89 days ago) for $2.25 per share
| Pay Date | Amount |
|---|---|
| September 6, 2024 | $2.25 |
| June 7, 2024 | $2.25 |
| March 7, 2024 | $2.25 |
| December 8, 2023 | $2.13 |
| September 8, 2023 | $2.13 |
| June 8, 2023 | $2.13 |
| March 8, 2023 | $2.13 |
| December 8, 2022 | $1.94 |
| September 8, 2022 | $1.94 |
| June 8, 2022 | $1.94 |
| March 8, 2022 | $1.94 |
| December 8, 2021 | $1.76 |
| September 8, 2021 | $1.76 |
| June 8, 2021 | $1.76 |
| March 8, 2021 | $1.76 |
| December 8, 2020 | $1.6 |
| September 8, 2020 | $1.6 |
| June 8, 2020 | $1.6 |
| March 6, 2020 | $1.6 |
| December 6, 2019 | $1.45 |
| September 6, 2019 | $1.45 |
| June 7, 2019 | $1.45 |
| March 8, 2019 | $1.45 |
| December 7, 2018 | $1.32 |
| September 7, 2018 | $1.32 |
| June 8, 2018 | $1.32 |
| March 8, 2018 | $1.32 |
| December 8, 2017 | $1.15 |
| September 8, 2017 | $1.15 |
| June 8, 2017 | $1.15 |
| March 8, 2017 | $1.15 |
| December 8, 2016 | $1 |
| September 8, 2016 | $1 |
| June 8, 2016 | $1 |
| March 8, 2016 | $1 |
| December 7, 2015 | $0.79 |
| September 8, 2015 | $0.79 |
| June 5, 2015 | $0.79 |
| March 6, 2015 | $0.79 |
| December 5, 2014 | $0.61 |
| September 5, 2014 | $0.61 |
| June 6, 2014 | $0.61 |
| March 7, 2014 | $0.61 |
| December 6, 2013 | $0.47 |
| September 6, 2013 | $0.47 |
| June 7, 2013 | $0.47 |
| March 7, 2013 | $0.47 |
| December 7, 2012 | $0.36 |
| September 7, 2012 | $0.36 |
| June 7, 2012 | $0.36 |
| March 7, 2012 | $0.36 |
| December 8, 2011 | $0.28 |
| September 8, 2011 | $0.28 |
Dividend data last updated Wed, 04 Dec 2024 23:24:46 GMT UTC